Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.
Lipworth BJ, Collier DJ, Gon Y, Zhong N, Nishi K, Chen R, Arora S, Maes A, Siddiqui S, Reisner C, Martin UJ. Lipworth BJ, et al. Among authors: gon y. Int J Chron Obstruct Pulmon Dis. 2018 Sep 26;13:2969-2984. doi: 10.2147/COPD.S171835. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30310273 Free PMC article. Clinical Trial.
Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T, Okada K, Furuichi S, Ishiguro T, Yoshizawa A, Akahoshi T, Gon Y, Akashiba T, Hosokawa Y, Hashimoto S. Yoshizawa T, et al. Among authors: gon y. Int J Chron Obstruct Pulmon Dis. 2015 Jul 6;10:1283-9. doi: 10.2147/COPD.S80673. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26185434 Free PMC article.
Autophagy, selective autophagy, and necroptosis in COPD.
Mizumura K, Maruoka S, Shimizu T, Gon Y. Mizumura K, et al. Among authors: gon y. Int J Chron Obstruct Pulmon Dis. 2018 Oct 9;13:3165-3172. doi: 10.2147/COPD.S175830. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30349225 Free PMC article. Review.
Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease.
Gon Y, Nishi K, Sato K, Maes A, Siddiqui S, Hayashi N, Hirata H, Martin UJ, Reisner C. Gon Y, et al. Respir Investig. 2021 Jan;59(1):135-144. doi: 10.1016/j.resinv.2020.06.007. Epub 2020 Sep 8. Respir Investig. 2021. PMID: 32917556 Clinical Trial.
Asthma and COPD overlap pathophysiology of ACO.
Hikichi M, Hashimoto S, Gon Y. Hikichi M, et al. Among authors: gon y. Allergol Int. 2018 Apr;67(2):179-186. doi: 10.1016/j.alit.2018.01.001. Epub 2018 Mar 15. Allergol Int. 2018. PMID: 29550368 Free article. Review.
Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
van Zyl-Smit RN, Krüll M, Gessner C, Gon Y, Noga O, Richard A, de Los Reyes A, Shu X, Pethe A, Tanase AM, D'Andrea P; PALLADIUM trial investigators. van Zyl-Smit RN, et al. Among authors: gon y. Lancet Respir Med. 2020 Oct;8(10):987-999. doi: 10.1016/S2213-2600(20)30178-8. Epub 2020 Jul 9. Lancet Respir Med. 2020. PMID: 32653075 Clinical Trial.
251 results